Cargando…

Drug treatment of inborn errors of metabolism: a systematic review

BACKGROUND: The treatment of inborn errors of metabolism (IEM) has seen significant advances over the last decade. Many medicines have been developed and the survival rates of some patients with IEM have improved. Dosages of drugs used for the treatment of various IEM can be obtained from a range of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alfadhel, Majid, Al-Thihli, Khalid, Moubayed, Hiba, Eyaid, Wafaa, Al-Jeraisy, Majed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Drug Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693126/ https://www.ncbi.nlm.nih.gov/pubmed/23532493 http://dx.doi.org/10.1136/archdischild-2012-303131

Ejemplares similares

Thirteen year retrospective review of the spectrum of inborn errors of metabolism presenting in a tertiary center in Saudi Arabia
por: Alfadhel, Majid, et al.
Publicado: (2016)

Carnitine Inborn Errors of Metabolism
por: Almannai, Mohammed, et al.
Publicado: (2019)

Assessment of methylcitrate and methylcitrate to citrate ratio in dried blood spots as biomarkers for inborn errors of propionate metabolism
por: Al-Dirbashi, Osama Y., et al.
Publicado: (2019)

Ciprofloxacin safety in paediatrics: a systematic review
por: Adefurin, Abiodun, et al.
Publicado: (2011)

Safety of ceftriaxone in paediatrics: a systematic review
por: Zeng, Linan, et al.
Publicado: (2020)

Drug use and upper gastrointestinal complications in children: a case–control study
por: Bianciotto, Manuela, et al.
Publicado: (2013)

Lack of a significant change in caffeine metabolism in underweight children as determined by the caffeine breath test
por: Oshikoya, K A, et al.
Publicado: (2015)

Systematic review of the toxicity of short-course oral corticosteroids in children
por: Aljebab, Fahad, et al.
Publicado: (2016)

Cut-off values in newborn screening for inborn errors of metabolism in Saudi Arabia
por: Khan, Adbul Rafiq, et al.
Publicado: (2022)

Treatment of inborn errors of metabolism
por: Jalan, Anil B
Publicado: (2014)

Safety of new medicines in young children
por: Choonara, Imti
Publicado: (2011)

Acceptability of different oral formulations in infants and preschool children
por: van Riet-Nales, Diana A, et al.
Publicado: (2013)

Rational prescribing is important in all settings
por: Choonara, Imti
Publicado: (2013)

Paediatric clinical pharmacology in the UK
por: Choonara, Imti, et al.
Publicado: (2014)

How safe is paracetamol?
por: Star, Kristina, et al.
Publicado: (2015)

Inter-individual variation in midazolam clearance in children
por: Altamimi, Mohammed I, et al.
Publicado: (2015)

Observational study on the palatability and tolerability of oral prednisolone and oral dexamethasone in children in Saudi Arabia and the UK
por: Aljebab, Fahad, et al.
Publicado: (2018)

Biosimilar infliximab use in paediatric IBD
por: Richmond, Lisa, et al.
Publicado: (2018)

Predictors of intravenous amiodarone induced liver injury
por: Diab, O.A., et al.
Publicado: (2017)

Additivity of nebivolol/valsartan single‐pill combinations versus other single‐pill combinations for hypertension
por: Ishak, Jack, et al.
Publicado: (2017)

Pharmacokinetic studies in children: recommendations for practice and research
por: Barker, Charlotte I S, et al.
Publicado: (2018)

Neonatal outcomes following new reimbursement limitations on palivizumab in Italy
por: Belleudi, Valeria, et al.
Publicado: (2018)

Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects
por: van Riet-Nales, Diana A, et al.
Publicado: (2016)

PCSK9 Monoclonal Antibodies: An Overview
por: Kaddoura, Rasha, et al.
Publicado: (2020)

Can parents believe websites’ information about methylphenidate’s side effects?
por: Arsac England, Tom, et al.
Publicado: (2021)

Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis
por: Ruslami, Rovina, et al.
Publicado: (2022)

Assessment of mitochondrial toxicity in newborns and infants with congenital cytomegalovirus infection treated with valganciclovir
por: Ortiz-Gracia, Alba, et al.
Publicado: (2022)

Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants
por: Pfiffner, Miriam, et al.
Publicado: (2023)

Mucolipidosis II: first report from Saudi Arabia
por: Alfadhel, Majid, et al.
Publicado: (2013)

DDIEM: drug database for inborn errors of metabolism
por: Abdelhakim, Marwa, et al.
Publicado: (2020)

The impact of consanguinity on the frequency of inborn errors of metabolism
por: Afzal, Raja Majid, et al.
Publicado: (2018)

GARROD'S INBORN ERRORS OF METABOLISM
Publicado: (1963)

Inborn Errors of Metabolism in Humans
por: Grossbard, Michael
Publicado: (1983)

Inborn errors in the metabolism of glutathione
por: Ristoff, Ellinor, et al.
Publicado: (2007)

Garrod's Inborn Errors of Metabolism
por: Goldhor, Susan
Publicado: (1964)

Dysmorphology of inborn errors of metabolism
por: Kimonis, Virginia
Publicado: (2014)

Exploiting epigenetics for the treatment of inborn errors of metabolism
por: Rutten, Martijn G. S., et al.
Publicado: (2019)

In vivo Metabolism of Nifurtimox and the Drug-Drug Interaction Potential Including its Major Metabolites
por: Schulz, Simone I., et al.
Publicado: (2023)

Flux analysis of inborn errors of metabolism
por: Reijngoud, D.-J.
Publicado: (2018)

Impact of pregnancy on inborn errors of metabolism
por: Wilcox, Gisela
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gjel8r6183rrgc7bn3ns230rcr